Jayant Talwalkar

Author PubWeight™ 28.91^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Design and endpoints of clinical trials in hepatocellular carcinoma.	J Natl Cancer Inst	2008	11.27
2	Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.	Hepatology	2010	5.00
3	Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.	Gastroenterology	2003	2.89
4	Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.	Hepatology	2014	1.83
5	Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis.	Clin Gastroenterol Hepatol	2010	1.48
6	A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury.	J Am Med Inform Assoc	2013	1.14
7	Portal hypertension correlates with splenic stiffness as measured with MR elastography.	J Magn Reson Imaging	2011	1.10
8	Automated liver stiffness measurements with magnetic resonance elastography.	J Magn Reson Imaging	2012	1.10
9	Efficacy, effectiveness, and comparative effectiveness in liver disease.	Hepatology	2010	1.04
10	Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis.	Am J Gastroenterol	2009	0.98
11	Graft vs. host disease after liver transplantation: a new approach is needed.	Liver Transpl	2007	0.88
12	A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension.	Liver Int	2009	0.84
13	Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up.	Liver Int	2009	0.79
14	Risk Factors and Outcomes of De novo Cancers (Excluding Nonmelanoma Skin Cancer) after Liver Transplantation for Primary Sclerosing Cholangitis.	Transplantation	2017	0.75